Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.17
+0.20 (0.86%)
At close: Oct 28, 2025, 4:00 PM EDT
24.15
-0.02 (-0.06%)
After-hours: Oct 28, 2025, 4:29 PM EDT
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$455,018
Profits / Employee
-$12,439
Market Cap
700.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 761 | 151 | 24.75% |
| Dec 31, 2023 | 610 | 67 | 12.34% |
| Dec 31, 2022 | 543 | 198 | 57.39% |
| Dec 31, 2021 | 345 | 144 | 71.64% |
| Dec 31, 2020 | 201 | 66 | 48.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CSTL News
- 12 hours ago - Castle Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 days ago - New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett's Esophagus - GlobeNewsWire
- 4 days ago - New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference - GlobeNewsWire
- 15 days ago - Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025 - GlobeNewsWire
- 27 days ago - Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - GlobeNewsWire
- 5 weeks ago - Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - GlobeNewsWire
- 5 weeks ago - Castle Biosciences Named One of Newsweek's America's Greatest Companies 2025 - GlobeNewsWire
- 7 weeks ago - New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett's Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions - GlobeNewsWire